Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
Julien Dufort‐Gervais(Hôpital du Sacré-Cœur de Montréal), Jonathan Brouillette(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal)
Cited by 50
Related Papers
Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
|Journal of Neuroscience|2012|171
Regulation of the <i>Neuroligin-1</i> Gene by Clock Transcription Factors
|Journal of Biological Rhythms|2018|13
Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats
|Alzheimer s Research & Therapy|2023|13
Evidence for a GABA<sub>B</sub> receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat
|British Journal of Pharmacology|2002|10